|
NGLY1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.149800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.343000E-01 |
| Normal-vs-Stage2 |
2.093800E-01 |
| Normal-vs-Stage3 |
3.491900E-02 |
| Normal-vs-Stage4 |
3.785500E-04 |
| Stage1-vs-Stage2 |
3.328000E-01 |
| Stage1-vs-Stage3 |
9.331800E-02 |
| Stage1-vs-Stage4 |
7.953900E-02 |
| Stage2-vs-Stage3 |
6.829000E-01 |
| Stage2-vs-Stage4 |
3.498200E-01 |
| Stage3-vs-Stage4 |
5.134200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.405200E-01 |
| Normal-vs-AfricanAmerican |
3.718800E-01 |
| Normal-vs-Asian |
9.200800E-01 |
| Caucasian-vs-AfricanAmerican |
7.918200E-01 |
| Caucasian-vs-Asian |
7.441000E-01 |
| AfricanAmerican-vs-Asian |
6.900400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.108400E-02 |
| Normal-vs-Female |
2.752000E-02 |
| Male-vs-Female |
2.613800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.076180E-01 |
| Normal-vs-Extreme_Weight |
4.086200E-02 |
| Normal-vs-Obese |
1.982200E-01 |
| Normal-vs-Extreme_Obese |
9.704000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.456000E-01 |
| Normal_Weight-vs-Obese |
7.741600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.040200E-01 |
| Extreme_Weight-vs-Obese |
6.840200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.839600E-01 |
| Obese-vs-Extreme_Obese |
6.795800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.765000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.697200E-01 |
| Normal-vs-Age(61-80Yrs) |
4.790800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.521000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.648800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.406600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.730850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.352600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.873600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.263600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.782800E-01 |
| Normal-VS-Type2 PRCC |
5.997700E-02 |
| Normal-VS-KIRP CIMP |
5.223800E-01 |
| Normal-VS-Unclassified PRCC |
5.866800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.030420E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.132800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.864400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.059600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.377200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.201200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.006800E-04 |
| Normal-vs-N1 |
2.109800E-01 |
| Normal-vs-N2 |
1.178480E-04 |
| N0-vs-N1 |
2.664800E-01 |
| N0-vs-N2 |
1.762380E-01 |
| N1-vs-N2 |
8.839600E-02 |
|
|
